HighMark Wealth Management’s Enzo Biochem, Inc. ENZ Stock Holding History

HighMark Wealth Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,815	Closed	-$5K	–	514
2020 Q4	$5K	Hold	1,815	–	–	﹤0.01%	342
2020 Q3	$4K	Hold	1,815	–	–	﹤0.01%	356
2020 Q2	$4K	Hold	1,815	–	–	﹤0.01%	347
2020 Q1	$4K	Hold	1,815	–	–	﹤0.01%	258
2019 Q4	$4K	Buy	+1,815	New	+$5.42K	﹤0.01%	316

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HighMark Wealth Management's ENZ Position: Q1 2021 in Review

HighMark Wealth Management sold out of Enzo Biochem, Inc. (ENZ) in Q1 2021, closing a stake of 1,815 shares — an estimated $5K sold.

HighMark Wealth Management first reported a position in ENZ in Q4 2019 and held it in 5 quarters. The position peaked at $5K in Q4 2020. 82 funds tracked by Wall St. Rank hold ENZ as of Q1 2021.

HighMark Wealth Management reported no remaining Enzo Biochem, Inc. position as of Q1 2021 after selling out during the quarter.
HighMark Wealth Management sold 1,815 Enzo Biochem, Inc. shares in Q1 2021, an estimated $5K.
HighMark Wealth Management first reported a position in Enzo Biochem, Inc. in Q4 2019 and held it in 5 quarters.
HighMark Wealth Management's Enzo Biochem, Inc. position peaked at $5K in Q4 2020.
82 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2021.

Based on HighMark Wealth Management's 13F filing for Q1 2021, filed 22 Apr 2021.